Learn more

DU PONT MERCK PHARMA

Overview
  • Total Patents
    1,292
About

DU PONT MERCK PHARMA has a total of 1,292 patent applications. Its first patent ever was published in 1979. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are TAVARES FRANCIS XAVIER, SINT QUIMICA SA and BUZAS ANDRE.

Patent filings per year

Chart showing DU PONT MERCK PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Degrado William Frank 83
#2 Batt Douglas Guy 72
#3 Wityak John 66
#4 Jadhav Prabhakar Kondaji 60
#5 Sun Jung-Hui 58
#6 Hodge Carl Nicholas 53
#7 Edwards David Scott 51
#8 Xue Chu-Biao 48
#9 Mousa Shaker Ahmed 47
#10 Sworin Michael 46

Latest patents

Publication Filing date Title
AU9742601A Novel radiopharmaceutical compositions and matrices and uses thereof
ZA9805818B Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
WO9857934A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS
ZA9805251B Inhibitors of factor Xa with a neutral P1 specificity group.
ZA9805247B Guanidine mimics as factor Xa inhibitors.
ZA9804788B Crystalline roxifiban.
AU6791198A Plate apparatus for holding small volumes of liquids
AU6780398A Heterocyclic integrin inhibitor prodrugs
CZ337299A3 Dynamic splitting of isoxazoline thioesters catalyzed with lipase to isoxazolinecarboxylic acids
ZA9802339B 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors.
ZA9711586B Nitrogen containing heteroaromatics as factor Xa inhibitors.
ZA9711256B Asymmetric synthesis of benzoxazinones
WO9828269A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
ZA9709867B 1-(3-Aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
ZA9709868B A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor
CN1239895A Radiopharmaceuticals for imaging infection and inflammation
ZA9708758B Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
ZA9708759B 4,4-Disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
AU3970697A Cyclic carbamates and isoxazolidines as iib/iiia antagonists
AU3736197A A practical synthesis of benzoxazinones useful as hiv reverse transcripta se inhibitors